| Literature DB >> 29377512 |
Yan Zhang1, Xiaoli Xie1, Jixiao Zeng1, Qiang Wu1, Ruizhong Zhang1, Deli Zhu1, Huimin Xia1.
Abstract
Hirschsprung disease (HSCR) is a genetic disorder characterized by the absence of enteric ganglia. There are more than 15 genes identified as contributed to HSCR by family-based or population-based approaches. However, these findings were not fulfilled to explain the heritability of most sporadic cases. In this study, using 1470 HSCR and 1473 control subjects in South Chinese population, we replicated two variants in NRG1 (rs16879552, P = 1.05E-04 and rs7835688, P = 1.19E-07), and further clarified the two replicated SNPs were more essential for patients with short-segment aganglionosis (SHSCR) (P = 2.37E-05). We also tried to replicate the most prominent signal (rs7785360) in AUTS2, which was a potential susceptibility gene with HSCR. In our results, in terms of individual association, marginal effect was observed to affect the HSCR patients following recessive model (P = 0.089). Noteworthy, significant intergenic synergistic effect between rs16879552 (NRG1) and rs7785360 (AUTS2) was identified through cross-validation by logistic regression (P = 2.45E-03, OR = 1.53) and multifactor dimensionality reduction (MDR, P < 0.0001, OR = 1.77). Significant correlation was observed between expression of these two genes in the normal segments of the colons (P = 0.018), together with differential expression of these genes between aganglionic colonic segments and normal colonic segments of the HSCR patients (P value for AUTS2 <0.0001, P value for NRG1 = 0.0243). Although functional evaluation is required, we supply new evidence for the NRG1 to HSCR and raised up a new susceptibility gene AUTS2 to a specific symptom for the disease.Entities:
Keywords: Hirschsprung disease; association; epistasis; subclinical stratification
Mesh:
Substances:
Year: 2018 PMID: 29377512 PMCID: PMC5867083 DOI: 10.1111/jcmm.13498
Source DB: PubMed Journal: J Cell Mol Med ISSN: 1582-1838 Impact factor: 5.310
Replication results of three SNPs on NRG1 and AUTS2 in South Chinese population using 1470 cases and 1473 controls
| CHR | SNP | BP | A1/A2 | Gene | Feature | Left_gene | Right_gene | TEST | Case | Control | OR (CI 0.95) |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||
| 7 | rs7785360 | 69944392 | G/A |
| intron [NM_015570.1] | STAG3L4 | WBSCR17 | Freq | 91.88% | 90.82% | 1.14 (0.95–1.37) | 0.149 |
| ADD | 2659/235 | 2650/230 | 1.14 (0.95–1.37) | 0.152 | ||||||||
| DOM | 1433/14 | 1448/11 | 0.77 (0.35–1.72) | 0.534 | ||||||||
| REC | 1226/221 | 1202/257 | 1.19 (0.97–1.44) | 0.089 | ||||||||
| GENO | 1226/207/14 | 1202/246/11 | NA | 0.143 | ||||||||
|
| ||||||||||||
| 8 | rs16879552 | 32553698 | C/T |
| intron [NM_013964.2] | LOC100127894 | MST131 | Freq | 48.60% | 43.45% | 1.23 (1.11–1.37) | 1.05E‐04 |
| ADD | 1349/1427 | 1247/1623 | 1.23 (1.11–1.37) | 1.13E‐04 | ||||||||
| DOM | 1008/380 | 987/448 | 1.20 (1.02–1.42) | 0.025 | ||||||||
| REC | 341/1047 | 260/1175 | 1.47 (1.23–1.77) | 3.02E‐05 | ||||||||
| GENO | 341/667/380 | 260/727/448 | NA | 1.12E‐04 | ||||||||
|
| ||||||||||||
| 8 | rs7835688 | 32553981 | C/G |
| intron [NM_013964.2] | LOC100127894 | MST131 | Freq | 22.10% | 16.60% | 1.43 (1.25–1.63) | 1.19E‐07 |
| ADD | 633/2231 | 483/2427 | 1.42 (1.25–1.62) | 1.72E‐07 | ||||||||
| DOM | 551/881 | 450/1005 | 1.40 (1.20–1.63) | 2.09E‐05 | ||||||||
| REC | 82/1350 | 33/1422 | 2.62 (1.74–3.95) | 4.43E‐06 | ||||||||
| GENO | 82/469/881 | 33/417/1005 | NA | 2.52E‐07 | ||||||||
CHR, chromosome; SNP, single‐nucleotide polymorphism; BP, base pair of where the SNP is located. Func.refgene, the function role of SNP in the gene; Gene.refgene, the gene where the SNP located to; A1/A2 indicates the risk allele and protective allele to disease; Freq indicates risk allele frequency of the SNP in cases or controls. ADD, DOM, REC and GENO indicate the association test following additive, dominant, recessive and genotypic models. The P value indicates the significance based on different genetic models. The calculation of odds ratio (OR) is also based on the risk allele of each SNP.
Independence test by adjusting for the effects of other SNPs in the NRG1 region
| SNP | SNP whose effect was adjusted | |
|---|---|---|
| rs16879552 | rs7835688 | |
| rs16879552 | NA |
|
| OR = 1.08 (0.96–1.23) | ||
| rs7835688 |
| NA |
|
| ||
The data in each column represent the remaining effect of association (P‐values) after adjusting for the effect of SNP(s) on the top row of each column. SNPs with P value surpassing statistical significance (0.05) were boldfaced.
Pairwise epistatic interacting results among three variants in NRG1 and AUTS2 carried out by logistic regression and multifactor dimensionality reduction (MDR)
|
|
| |||
|---|---|---|---|---|
| SNP | Interaction | rs7785360 | rs16879552 | rs7835688 |
| Logistic regression | ||||
| rs7785360 | MDR | NA |
|
|
|
| OR = 1.36 (0.97–1.91) | |||
| rs16879552 | CVC = 10, BA = 0.543 | NA |
| |
| OR = 1.77 (1.46–2.14), | OR = 1.25 (0.99–1.59) | |||
| rs7835688 | NA | |||
OR means odds ratio for interaction, and a value of 1.0 indicates no effect. Cross‐validation consistency (CVC) reflects the number of times MDR analysis identified the same model as the data were divided into different segments. Balanced accuracy is defined as (sensitivity +specificity)/2. SNPs with P value surpassing statistical significance (0.05) were boldfaced.
Association results of three SNPs in NRG1 and AUTS2 to different subclinical features classified by aganglionosis length including short length (SHSCR), long length (LHSCR) and TCA
| CHR | SNP | A1/A2 | Gene | Length of aganglionosis | TEST | Case | Control | OR (CI 0.95) |
|
|---|---|---|---|---|---|---|---|---|---|
| 7 | rs7785360 | G/A | AUTS2 | SHSCR (1033 cases and 1473 controls) | Freq | 91.36% | 90.82% | 1.07 (0.88–1.31) | 0.51 |
| ADD | 964/978 | 2650/268 | 1.40 (0.98–1.98) | 0.51 | |||||
| DOM | 716/255 | 1448/11 | 2.18 (0.28–16.95) | 0.2 | |||||
| REC | 248/723 | 1202/257 | 1.41 (0.97–2.03) | 0.29 | |||||
| GENO | 248/468/255 | 1202/246/11 | NA | 0.17 | |||||
| LHSCR (294 cases and 1473 controls) | Freq | 93.23% | 90.82% | 1.39 (0.98–1.97) | 0.06 | ||||
| ADD | 537/39 | 2650/268 | 1.40 (0.98–1.98) |
| |||||
| DOM | 287/1 | 1448/11 | 2.18 (0.28–16.95) | 0.46 | |||||
| REC | 250/38 | 1202/257 | 1.41 (0.97–2.03) | 0.07 | |||||
| GENO | 250/37/1 | 1202/246/11 | NA | 0.18 | |||||
| TCA (82 cases) | Freq | 92.35% | 90.82% | 1.22 (0.68–2.18) | 0.5 | ||||
| ADD | 157/13 | 2650/268 | 1.23 (0.68–2.19) | 0.5 | |||||
| DOM | 85/0 | 1448/11 | NA | NA | |||||
| REC | 72/13 | 1202/257 | 1.18 (0.65–2.17) | 0.58 | |||||
| GENO | 72/13/0 | 1202/246/11 | NA | NA | |||||
| 8 | rs16879552 | C/T | NRG1 | SHSCR (1033 cases and 1473 controls) | Freq | 49.64% | 43.45% | 1.28 (1.14–1.44) |
|
| ADD | 1862/176 | 1247/1623 | 1.10 (0.91–1.32) |
| |||||
| DOM | 1006/13 | 987/448 | 1.08 (0.81–1.43) |
| |||||
| REC | 856/163 | 260/1175 | 1.21 (0.88–1.66) |
| |||||
| GENO | 856/150/13 | 260/727/448 | NA |
| |||||
| LHSCR (294 cases and 1473 controls) | Freq | 45.71% | 43.45% | 1.10 (0.91–1.32) | 0.32 | ||||
| ADD | 256/304 | 1247/1623 | 1.10 (0.91–1.32) | 0.32 | |||||
| DOM | 197/83 | 987/448 | 1.08 (0.81–1.43) | 0.6 | |||||
| REC | 59/221 | 260/1175 | 1.21 (0.88–1.66) | 0.25 | |||||
| GENO | 59/138/83 | 260/727/448 | NA | 0.5 | |||||
| TCA (82 cases) | Freq | 45.12% | 43.45% | 1.07 (0.78–1.47) | 0.67 | ||||
| ADD | 74/90 | 1247/1623 | 1.07 (0.78–1.48) | 0.67 | |||||
| DOM | 58/24 | 987/448 | 1.10 (0.67–1.79) | 0.71 | |||||
| REC | 16/66 | 260/1175 | 1.10 (0.62–1.92) | 0.75 | |||||
| GENO | 16/42/24 | 260/727/448 | NA | 0.91 | |||||
| 8 | rs7835688 | C/G | NRG1 | SHSCR (1033 cases and 1473 controls) | Freq | 22.61% | 16.60% | 1.47 (1.27–1.69) |
|
| ADD | 458/1568 | 483/2427 | 1.46 (1.27–1.68) |
| |||||
| DOM | 393/620 | 450/1005 | 1.42 (1.20–1.68) |
| |||||
| REC | 65/948 | 33/1422 | 2.96 (1.93–4.53) |
| |||||
| GENO | 65/328/620 | 33/417/1005 | NA |
| |||||
| LHSCR (294 cases and 1473 controls) | Freq | 20.04% | 16.60% | 1.26 (1.00–1.58) | 0.05 | ||||
| ADD | 113/451 | 483/2427 | 1.27 (1.01–1.60) | 0.05 | |||||
| DOM | 100/182 | 450/1005 | 1.23 (0.94–1.60) | 0.13 | |||||
| REC | 13/269 | 33/1422 | 2.08 (1.08–4.01) | 0.03 | |||||
| GENO | 13/87/182 | 33/417/1005 | NA | 0.06 | |||||
| TCA (82 cases) | Freq | 24.39% | 16.60% | 1.62 (1.12–2.35) |
| ||||
| ADD | 40/124 | 483/2427 | 1.67 (1.14–2.45) |
| |||||
| DOM | 39/43 | 450/1005 | 2.03 (1.30–3.17) |
| |||||
| REC | 1/81 | 33/1422 | 0.53 (0.07–3.94) | 0.54 | |||||
| GENO | 1/38/43 | 33/417/1005 | NA |
|
SNPs with P value surpassing statistical significance (0.05) were boldfaced.
Figure 1Tissue‐specific differential expression of NRG1 and AUTS2 in aganglionic and dilated (normal) colons of the HSCR patients.